Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Capital/Financing Update 2021

Apr 28, 2021

61842_rns_2021-04-28_760ce185-6e15-40ce-8bf0-92d79762510c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Communication Address: Solara Active Pharma Sciences Limited Batra Centre

No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in

April 28, 2021

The BSE Limited

Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001 Scrip Code: 541540

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Sandra (E), Mumbai - 400 051

Scrip Code: SOLARA

Dear Sir/ Madam,

Sub: Update on Consolidation of Shareholding in Sequent Penems Private Limited (SPPL) to make SPPL a Wholly Owned Subsidiary of the Company.

This has reference to our earlier letter dated February 3, 2021 wherein, the Board has approved to acquire additional share capital in Sequent Penems Private Limited (SPPL) (subsidiary of Solara), to make it as a wholly owned subsidiary of Solara was informed.

With this we wish to confirm that he above said transaction is completed and Sequent Penems Private limited is wholly owned subsidiary of Solara Active Pharma Sciences with effect from April 27, 2021.

This is for your information and appropriate dissemination..

Thanking you, Yours Truly,

For Solara Active Pharma Sciences Limited

==> picture [146 x 39] intentionally omitted <==

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942